ClassID:

2187

A01K2217/075 - page 7 - CPC Classification

Classification description:

Genetically modified animals; Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Recent Application in this class:
#1801
20050177885
2005-08-11

CCN1 transgenic animals

#1802
20050177884
2005-08-11

Chimeric nonhuman animal

#1803
20050176050
2005-08-11

Genes encoding several poly(ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith

#1804
20050176041
2005-08-11

Secreted and transmembrane polypeptides and nucleic acids encoding the same

#1805
20050176021
2005-08-11

Human RalGDS-like protein 3

#1806
20050175612
2005-08-11

Polynucleotides encoding growth differentiation factor-8

#1807
20050171336
2005-08-04

Murine ortholog of the human disrupted-in-schizophrenia 1 gene

#1808
20050170489
2005-08-04

Beta-secretase enzyme compositions and methods

#1809
20050170452
2005-08-04

Method to engineer mammalian-type carbohydrate structures

#1810
20050170334
2005-08-04

Human monoclonal antibodies to influenza M2 protein and methods of making and using same

#1811
20050169927
2005-08-04

Human tissue factor antibodies

#1812
20050164344
2005-07-28

Protein encoded by a nucleic acid

#1813
20050164327
2005-07-28

Beta-secretase enzyme compositions and methods

#1814
20050164294
2005-07-28

β-secretase enzyme compositions and methods

#1815
20050164266
2005-07-28

Secreted and transmembrane polypeptides and nucleic acids encoding the same

#1816
20050160485
2005-07-21

Mouse in which genome is modified

#1817
20050159373
2005-07-21

Novel polypeptides, and nucleic acids encoding the same

#1818
20050158800
2005-07-21

G-coupled receptor showing selective affinity for ATP

#1819
20050158310
2005-07-21

Methods and compositions for preventing obesity and obesity related disorders

#1820
20050155097
2005-07-14

Eosinophil-deficient transgenic animals

#1821
20050155095
2005-07-14

Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region

#1822
20050155094
2005-07-14

Swine rag-1 gene and utilization thereof

#1823
20050153922
2005-07-14

Methods for modulating the activity of MSH-5

#1824
20050152876
2005-07-14

Compositions and methods for treating female fertility

#1825
20050149993
2005-07-07

Methods for treating circadian rhythm phase disturbances

#1826
20050147995
2005-07-07

Tumor suppressor designated TS10q23.3

#1827
20050147969
2005-07-07

Genes associated with mast cell activation

#1828
20050147967
2005-07-07

Novel neuronally expressed protein and use thereof

#1829
20050144662
2005-06-30

Knockout mouse

#1830
20050144660
2005-06-30

Mouse models for studying and treating hepatocellular and gastrointestinal tumors

#1831
20050144659
2005-06-30

Animals and cells containing a mutated alpha2delta gene

#1832
20050142561
2005-06-30

Intracellular signaling pathways in diabetic subjects

#1833
20050142137
2005-06-30

Antibodies against secretoryleukocyte protease inhibitor

#1834
20050136050
2005-06-23

Bispecific antibodies

#1835
20050136039
2005-06-23

Adipocytes and uses thereof

#1836
20050132429
2005-06-16

Non-human mutant mammals deficient in Sigma receptors and their applications

#1837
20050132428
2005-06-16

Cyclic amp phosphodiesterase 4d7 isoforms and methods of use

#1838
20050132427
2005-06-16

Animal model for the analysis of tumor metastasis

#1839
20050130926
2005-06-16

HX2004-6 polypeptide expressed in cancerous cells

#1840
20050130265
2005-06-16

Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof

#1841
20050129683
2005-06-16

Human testis expressed patched like protein

#1842
20050125851
2005-06-09

Methods of diagnosis and treatment of interstitial lung disease

#1843
20050124796
2005-06-09

Mouse cytokine receptor Zcytor16

#1844
20050123978
2005-06-09

Knockout mouse for the tumor suppressor gene ANX7

#1845
20050123963
2005-06-09

Methods of identifying and using chemotherapeutic agents

#1846
20050123953
2005-06-09

Novel human kinase and polynucleotides encoding the same

#1847
20050120401
2005-06-02

Method for targeting transcriptionally active loci

#1848
20050120400
2005-06-02

α(1,3)-galactosyltransferase knockout swine, tissues and organs

#1849
20050120395
2005-06-02

Method for genetically modifying a target population of an organism

#1850
20050120392
2005-06-02

Transgenic zebrafish models for thrombosis

#1851
20050119536
2005-06-02

Diagnostics and therapeutics for arterial wall disruptive disorders

#1852
20050119209
2005-06-02

Compositions and methods for the treatment and diagnosis of immune disorders

#1853
20050114913
2005-05-26

Methods and compositions for generating homozygous mutations

#1854
20050114910
2005-05-26

Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications

#1855
20050112618
2005-05-26

Secreted protein

#1856
20050112579
2005-05-26

Nucleic acid molecules encoding serine protease 16, the encoded polypeptides and methods based thereon

#1857
20050108783
2005-05-19

Porcine invariant chain protein, full length cDNA, genomic organization, and regulatory region

#1858
20050108782
2005-05-19

Transgenic RS1-/- animal and uses thereof

#1859
20050107313
2005-05-19

Tumour suppressor gene

#1860
20050106679
2005-05-19

Leptin proteins

#1861
20050106628
2005-05-19

MEGSIN protein

#1862
20050106600
2005-05-19

Compositions and methods for the diagnosis, prevention and treatment of tumor progression

#1863
20050106099
2005-05-19

Expressed ligand-vascular intercellular signaling molecule

#1864
20050101536
2005-05-12

Modulation of angiogenesis

#1865
20050100884
2005-05-12

Method of detecting disease conditions in infected with animal virus

#1866
20050096460
2005-05-05

β-amyloid peptide-binding proteins and polynucleotides encoding the same

#1867
20050095620
2005-05-05

Vectors for making genomic modifications

#1868
20050095227
2005-05-05

Treating heart failure

#1869
20050091704
2005-04-28

Ant2 conditional knockout mouse and methods

#1870
20050091703
2005-04-28

Nonhuman model animal of Th2-mediated hyperimmune response

#1871
20050090003
2005-04-28

P2x7 receptor-deficient non-human animals and uses thereof

#1872
20050089937
2005-04-28

DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof

#1873
20050086709
2005-04-21

7B2 knockout transgenic animals as models of endocrine disease

#1874
20050085627
2005-04-21

Atopy

#1875
20050081257
2005-04-14

Method of producing non-human mammals

#1876
20050079558
2005-04-14

Methods to identify compounds useful for the treatment of proliferative and differentiative disorders

#1877
20050079160
2005-04-14

OSR-1 nucleic acids and proteins

#1878
20050076395
2005-04-07

Generation of xenogeneic antibodies

#1879
20050071895
2005-03-31

Generation of transgenic mice by transgene-mediated rescue of spermatogenesis

#1880
20050071894
2005-03-31

Nonhuman model animal lacking the ability to control lymphocyte migration

#1881
20050070699
2005-03-31

HBM variants that modulate bone mass and lipid levels

#1882
20050066381
2005-03-24

Regulation of cardiac contractility and heart failure propensity

#1883
20050066380
2005-03-24

PERV screening method and use thereof

#1884
20050066378
2005-03-24

Non-human animal model of systemic lupus erythematosus

#1885
20050066375
2005-03-24

Cell and transgenic animal modelling human antigenic presentation and their uses

#1886
20050065328
2005-03-24

Gastrokines and derived peptides including inhibitors

#1887
20050064405
2005-03-24

Gene involved in V(D)J recombination and/or DNA repair

#1888
20050063982
2005-03-24

GRP94-based compositions and methods of use thereof

#1889
20050060763
2005-03-17

Mouse λ light chain locus

#1890
20050059618
2005-03-17

Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis

#1891
20050059586
2005-03-17

Identification of ses-3 and the uses of the same

#1892
20050054564
2005-03-10

Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors

#1893
20050054055
2005-03-10

Human antibodies derived from immunized xenomice

#1894
20050054013
2005-03-10

Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders

#1895
20050053983
2005-03-10

Novel serine protease BSSP4

#1896
20050049409
2005-03-03

Novel human proteases and polynucleotides encoding the same

#1897
20050049194
2005-03-03

Use of ephrins and related molecules to regulate cellular proliferation

#1898
20050044584
2005-02-24

LKB1 gene knockout animals

#1899
20050044582
2005-02-24

Novel polynucleotides and uses therefor

#1900
20050044581
2005-02-24

Animals and cells containing a mutated alpha2/omega1 gene

#1901
20050044579
2005-02-24

Neurotransmitter signaling can regulate life span in

#1902
20050042731
2005-02-24

Secreted proteins

#1903
20050042671
2005-02-24

Modulation of angiogenesis

#1904
20050042643
2005-02-24

ELAVL-1

#1905
20050042226
2005-02-24

Treatment of chronic human viral hepatitis

#1906
20050039222
2005-02-17

Sgrf gene-modified non-human animals

#1907
20050039221
2005-02-17

Phenotypic effects of ubiquinone deficiencies and methods of screening thereof

#1908
20050037969
2005-02-17

Molecular interactions in hematopoietic cells

#1909
20050037966
2005-02-17

Keratinocyte growth factor-2

#1910
20050037962
2005-02-17

Syndecans and angiogenesis

#1911
20050037460
2005-02-17

Potassium channels and genes encoding these potassium channels

#1912
20050037455
2005-02-17

Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis

#1913
20050034185
2005-02-10

Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight

#1914
20050034184
2005-02-10

Transgenic mouse lacking PAPP-A activity

#1915
20050032692
2005-02-10

Methods of inhibiting tumor cell proliferation

#1916
20050031614
2005-02-10

Antibodies directed to parathyroid hormone (PTH) and uses thereof

#1917
20050031605
2005-02-10

Compositions and methods of treating diabetes

#1918
20050031582
2005-02-10

Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors

#1919
20050026292
2005-02-03

GLYT1 conditional knock-out mice

#1920
20050026278
2005-02-03

RNA interference mediating small RNA molecules

#1921
20050026255
2005-02-03

Corin, a serine protease

#1922
20050026248
2005-02-03

Novel mammalian G-protein coupled receptors having extracellular leucine rich repeat regions

#1923
20050022257
2005-01-27

Monitoring APP cleavage in transgenic rodents comprising an APP-Swedish mutation

#1924
20050020521
2005-01-27

In vivo gene silencing by chemically modified and stable siRNA

#1925
20050019838
2005-01-27

Novel human membrane-associated protein and cell surface protein family members

#1926
20050015822
2005-01-20

Mass 1 gene, a target for anticonvulsant drug development

#1927
20050014697
2005-01-20

Compositions and methods for modulating S-nitrosoglutathione reductase

#1928
20050003543
2005-01-06

Genome mutation by intron insertion into an embryonic stem cell genome

#1929
20050003541
2005-01-06

ES cells having enhanced RNAi effect

#1930
20050003427
2005-01-06

Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule

#1931
20050003407
2005-01-06

Method of screening for compounds that modulate activity of a regulatory sequence of the β-2 subunit of a neuronal nicotinic acetylcholine receptor

#1932
20050003363
2005-01-06

Method of screening for agents inhibiting chloride intracellular channels

#1933
20050002933
2005-01-06

Methods for modulating hematopoiesis and vascular growth

#1934
15294492
2020-03-03

Tools to detect, track and target cancer cells in vivo

#1935
10259226
2020-03-17

Methods and compositions for RNAi mediated inhibition of gene expression in mammals